- Home
- Publications
- Publication Search
- Publication Details
Title
PET Imaging Using Gallium-68 (68Ga) RM2
Authors
Keywords
-
Journal
PET Clinics
Volume 17, Issue 4, Pages 621-629
Publisher
Elsevier BV
Online
2022-09-22
DOI
10.1016/j.cpet.2022.07.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data
- (2022) Paola Mapelli et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
- (2021) Lucia Baratto et al. JOURNAL OF NUCLEAR MEDICINE
- Radiosynthesis and biological evaluation of 18F-labeled bispecific heterodimer targeted dual gastrin-releasing peptide receptor and prostate-specific membrane antigen for prostate cancer imaging
- (2021) Shimin Ye et al. NUCLEAR MEDICINE COMMUNICATIONS
- Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
- (2020) Edouard J. Trabulsi et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study
- (2020) Ida Sonni et al. JOURNAL OF NUCLEAR MEDICINE
- The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm
- (2020) Lucia Baratto et al. CLINICAL NUCLEAR MEDICINE
- Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
- (2020) Wolfgang P Fendler et al. JOURNAL OF NUCLEAR MEDICINE
- MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients
- (2020) Leonhard Gruber et al. JOURNAL OF NUCLEAR MEDICINE
- Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
- (2020) Thomas Franz Fassbender et al. EJNMMI Research
- Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples
- (2019) Romain Schollhammer et al. EJNMMI Research
- Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
- (2019) Ayman Abouzayed et al. Pharmaceutics
- Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements
- (2019) Lucia Baratto et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
- (2019) Bogdan Mitran et al. Cancers
- Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
- (2019) Sazan Rasul et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Screening for Prostate Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline
- (2018) Justin E. Bekelman et al. JOURNAL OF CLINICAL ONCOLOGY
- First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
- (2018) Silvano Gnesin et al. EJNMMI Research
- Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT
- (2017) Gesche Wieser et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective Evaluation of68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
- (2017) Ryogo Minamimoto et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease
- (2016) Arun Sasikumar et al. CLINICAL NUCLEAR MEDICINE
- Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT
- (2016) Benjamin Noto et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
- (2016) Mike Sathekge et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68 Ga/ 177 Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
- (2016) Simone U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
- (2016) Berthold A. Nock et al. JOURNAL OF NUCLEAR MEDICINE
- Bombesin-Like Receptor 3: Physiology of a Functional Orphan
- (2016) Cuiying Xiao et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
- (2016) Christian Stoykow et al. Theranostics
- Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
- (2016) Handoo Rhee et al. EJNMMI Research
- Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors
- (2016) Antonella Accardo et al. EJNMMI Research
- Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
- (2015) Steven P. Rowe et al. ANNALS OF NUCLEAR MEDICINE
- Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT
- (2015) Theodosia Maina et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
- (2015) Frederik A. Verburg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer
- (2015) S. U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
- (2015) Markus Dietlein et al. MOLECULAR IMAGING AND BIOLOGY
- Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
- (2015) B. Meller et al. EJNMMI Research
- [68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice
- (2014) Thomas Krohn et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo visualization of prostate-specific membrane antigen in glioblastoma
- (2014) Johannes Schwenck et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
- (2014) Gesche Wieser et al. Theranostics
- Gastrin-Releasing Peptide Receptor Expression in Lung Cancer
- (2013) Jane Mattei et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
- (2013) E. Kahkonen et al. CLINICAL CANCER RESEARCH
- Plasma Pharmacokinetics, Whole-Body Distribution, Metabolism, and Radiation Dosimetry of 68Ga Bombesin Antagonist BAY 86-7548 in Healthy Men
- (2013) A. Roivainen et al. JOURNAL OF NUCLEAR MEDICINE
- In Vitro and In Vivo Evaluation of a 18F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
- (2013) Zohreh Varasteh et al. PLoS One
- Early over-expression of GRP receptors in prostatic carcinogenesis
- (2013) Meike Körner et al. PROSTATE
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiopeptide Imaging and Therapy in Europe
- (2011) V. Ambrosini et al. JOURNAL OF NUCLEAR MEDICINE
- Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates
- (2011) Marc Beer et al. PROSTATE
- Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
- (2010) Rosalba Mansi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
- (2009) R. Mansi et al. CLINICAL CANCER RESEARCH
- Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer
- (2009) Hildo J.K. Ananias et al. PROSTATE
- Delayed Prostate-specific Antigen Recurrence After Radical Prostatectomy: How to Identify and What Are Their Clinical Outcomes?
- (2009) Arthur A. Caire et al. UROLOGY
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- (2008) R. T. Jensen et al. PHARMACOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now